2:PN:US20040072744 SEQID:2 claimed protein
CAS No. 389572-87-6
2:PN:US20040072744 SEQID:2 claimed protein( —— )
Catalog No. M29969 CAS No. 389572-87-6
2: PN: US20040072744 SEQID: 2 claimed protein is a synthetic peptide, used for the research of Down’s syndrome and schizophrenia.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 3645 | Get Quote |
|
| 10MG | 6156 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name2:PN:US20040072744 SEQID:2 claimed protein
-
NoteResearch use only, not for human use.
-
Brief Description2: PN: US20040072744 SEQID: 2 claimed protein is a synthetic peptide, used for the research of Down’s syndrome and schizophrenia.
-
Description2: PN: US20040072744 SEQID: 2 claimed protein is a synthetic peptide, used for the research of Down’s syndrome and schizophrenia.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number389572-87-6
-
Formula Weight1070.13
-
Molecular FormulaC43H67N13O17S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:Asn-Leu-Gly-Glu-His-Pro-Val-Cys-Asp-Ser
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Vina-ginsenoside R8
Vinaginsenoside R8, a triterpenoid glycoside isolated from the rhizomes of Panacis majoris. Vinaginsenoside R8 displays activities against adenosine diphosphate (ADP)-induced platelet aggregation (IC50=25.18 μM).
-
Ac-Gly-Ala-Lys(Ac)-A...
Ac-Gly-Ala-Lys(Ac)-AMC is a fluorogenic substrate for the determination of protease activity. Ac-Gly-Ala-Lys(Ac)-AMC undergoes hydrolysis and releases the fluorescent product 7-amino-4-methylcoumarin (AMC). AMC is fluorescent under UV light and can emit a fluorescent signal.
-
3,5-Di-O-caffeoylqui...
3,5-Di-O-caffeoylquinic acid methyl ester exhibits potent inhibitory activities against the formation of advanced glycation end products (AGEs); it exhibits cytotoxicity actions against human cervix carcinoma HeLa cells. 3,5-Di-O-caffeoylquinic acid methyl ester shows high efficiency and low toxicity with antivirus activity against RSV.
Cart
sales@molnova.com